These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Anti-monocyte chemoattractant protein-1 gene therapy limits progression and destabilization of established atherosclerosis in apolipoprotein E-knockout mice. Inoue S; Egashira K; Ni W; Kitamoto S; Usui M; Otani K; Ishibashi M; Hiasa K; Nishida K; Takeshita A Circulation; 2002 Nov; 106(21):2700-6. PubMed ID: 12438296 [TBL] [Abstract][Full Text] [Related]
4. Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis. Boring L; Gosling J; Cleary M; Charo IF Nature; 1998 Aug; 394(6696):894-7. PubMed ID: 9732872 [TBL] [Abstract][Full Text] [Related]
6. New anti-monocyte chemoattractant protein-1 gene therapy attenuates atherosclerosis in apolipoprotein E-knockout mice. Ni W; Egashira K; Kitamoto S; Kataoka C; Koyanagi M; Inoue S; Imaizumi K; Akiyama C; Nishida KI; Takeshita A Circulation; 2001 Apr; 103(16):2096-101. PubMed ID: 11319201 [TBL] [Abstract][Full Text] [Related]
7. HMG-CoA reductase inhibition reduces monocyte CC chemokine receptor 2 expression and monocyte chemoattractant protein-1-mediated monocyte recruitment in vivo. Han KH; Ryu J; Hong KH; Ko J; Pak YK; Kim JB; Park SW; Kim JJ Circulation; 2005 Mar; 111(11):1439-47. PubMed ID: 15781755 [TBL] [Abstract][Full Text] [Related]
8. Differential influence of chemokine receptors CCR2 and CXCR3 in development of atherosclerosis in vivo. Veillard NR; Steffens S; Pelli G; Lu B; Kwak BR; Gerard C; Charo IF; Mach F Circulation; 2005 Aug; 112(6):870-8. PubMed ID: 16061736 [TBL] [Abstract][Full Text] [Related]
9. Propagermanium reduces atherosclerosis in apolipoprotein E knockout mice via inhibition of macrophage infiltration. Yamashita T; Kawashima S; Ozaki M; Namiki M; Inoue N; Hirata K; Yokoyama M Arterioscler Thromb Vasc Biol; 2002 Jun; 22(6):969-74. PubMed ID: 12067906 [TBL] [Abstract][Full Text] [Related]
10. Crucial role of the CCL2/CCR2 axis in neointimal hyperplasia after arterial injury in hyperlipidemic mice involves early monocyte recruitment and CCL2 presentation on platelets. Schober A; Zernecke A; Liehn EA; von Hundelshausen P; Knarren S; Kuziel WA; Weber C Circ Res; 2004 Nov; 95(11):1125-33. PubMed ID: 15528472 [TBL] [Abstract][Full Text] [Related]
11. MCP-1 deficiency reduces susceptibility to atherosclerosis in mice that overexpress human apolipoprotein B. Gosling J; Slaymaker S; Gu L; Tseng S; Zlot CH; Young SG; Rollins BJ; Charo IF J Clin Invest; 1999 Mar; 103(6):773-8. PubMed ID: 10079097 [TBL] [Abstract][Full Text] [Related]
12. Localisation of mRNA for JE/MCP-1 and its receptor CCR2 in atherosclerotic lesions of the ApoE knockout mouse. Rayner K; Van Eersel S; Groot PH; Reape TJ J Vasc Res; 2000; 37(2):93-102. PubMed ID: 10754394 [TBL] [Abstract][Full Text] [Related]
13. Characterization of monocyte chemoattractant proteins and CC chemokine receptor 2 expression during atherogenesis in apolipoprotein E-null mice. Zhang S; Wang X; Zhang L; Yang X; Pan J; Ren G J Atheroscler Thromb; 2011; 18(10):846-56. PubMed ID: 21712615 [TBL] [Abstract][Full Text] [Related]
14. High-density lipoproteins suppress chemokines and chemokine receptors in vitro and in vivo. Bursill CA; Castro ML; Beattie DT; Nakhla S; van der Vorst E; Heather AK; Barter PJ; Rye KA Arterioscler Thromb Vasc Biol; 2010 Sep; 30(9):1773-8. PubMed ID: 20702809 [TBL] [Abstract][Full Text] [Related]
15. The presence of leukocyte CC-chemokine receptor 2 in CCR2 knockout mice promotes atherogenesis. Guo J; Van Eck M; de Waard V; Maeda N; Benson GM; Groot PH; Van Berkel TJ Biochim Biophys Acta; 2005 Jun; 1740(3):453-9. PubMed ID: 15949714 [TBL] [Abstract][Full Text] [Related]
16. Fractalkine deficiency markedly reduces macrophage accumulation and atherosclerotic lesion formation in CCR2-/- mice: evidence for independent chemokine functions in atherogenesis. Saederup N; Chan L; Lira SA; Charo IF Circulation; 2008 Apr; 117(13):1642-8. PubMed ID: 18165355 [TBL] [Abstract][Full Text] [Related]
17. Local monocyte chemoattractant protein-1 therapy increases collateral artery formation in apolipoprotein E-deficient mice but induces systemic monocytic CD11b expression, neointimal formation, and plaque progression. van Royen N; Hoefer I; Böttinger M; Hua J; Grundmann S; Voskuil M; Bode C; Schaper W; Buschmann I; Piek JJ Circ Res; 2003 Feb; 92(2):218-25. PubMed ID: 12574150 [TBL] [Abstract][Full Text] [Related]
18. Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E. Michelsen KS; Wong MH; Shah PK; Zhang W; Yano J; Doherty TM; Akira S; Rajavashisth TB; Arditi M Proc Natl Acad Sci U S A; 2004 Jul; 101(29):10679-84. PubMed ID: 15249654 [TBL] [Abstract][Full Text] [Related]
19. CCR5 deficiency is not protective in the early stages of atherogenesis in apoE knockout mice. Kuziel WA; Dawson TC; Quinones M; Garavito E; Chenaux G; Ahuja SS; Reddick RL; Maeda N Atherosclerosis; 2003 Mar; 167(1):25-32. PubMed ID: 12618265 [TBL] [Abstract][Full Text] [Related]
20. Repopulation of apolipoprotein E knockout mice with CCR2-deficient bone marrow progenitor cells does not inhibit ongoing atherosclerotic lesion development. Guo J; de Waard V; Van Eck M; Hildebrand RB; van Wanrooij EJ; Kuiper J; Maeda N; Benson GM; Groot PH; Van Berkel TJ Arterioscler Thromb Vasc Biol; 2005 May; 25(5):1014-9. PubMed ID: 15774908 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]